Roche Venture Fund
Venture capitalBasel · Series A · 2 people tracked
Team · 2 people
from the firm's websiteWhat they invest in
from 7 of 25 portfolio companiesBiotech ×7Medical Devices ×5Healthtech ×4Digital Health ×2AI & Machine Learning ×1Deep Tech ×1
HQs:Spain×1France×1United States×1
Investments · 25 tracked
founders shown can be your intro pathSpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes. The company is currently in clinical stages, with its lead program targeting Stargardt Disease.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
COUR develops targeted therapies for autoimmune diseases using an antigen-specific platform technology designed to restore immune tolerance while preserving normal immune function. The company focuses on disease-modifying treatments for immune-mediated conditions.
BiotechHealthtechMedical Devices
Entrada Therapeutics develops intracellular therapeutics using its EEV Platform to target previously inaccessible disease-causing targets within cells, with a pipeline spanning retinal, neuromuscular, and metabolic diseases including Duchenne muscular dystrophy.
BiotechHealthtechMedical DevicesBoston, US
Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
BiotechMedical Devices
Michael Kavanaugh(Founding Advisor)
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Riley Ennis(Co-Founder and Chief Product Officer)
Vivet Therapeutics is a company focused on gene and cell therapy development, presenting research at major scientific conferences.
BiotechParis, FR
Mironid develops drug therapies targeting cAMP degrading phosphodiesterase enzymes for autosomal dominant polycystic kidney disease and other rare kidney diseases with significant unmet medical needs.
BiotechHealthtechMedical Devices
Adele Rowley(Chief Scientific Officer)
Frequently asked questions
- What stage does Roche Venture Fund invest at?
- Roche Venture Fund invests at the Series A stage.
- What is Roche Venture Fund's typical check size?
- Roche Venture Fund typically writes checks of $648K – $3.2M.
- What sectors does Roche Venture Fund focus on?
- Roche Venture Fund focuses on Biotech, Medical Devices.
- Where is Roche Venture Fund located?
- Roche Venture Fund is headquartered in Basel, CH.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.